目的 比较恶性胆道梗阻患者经内镜下不同胆道支架治疗的临床效果及其安全性。方法 选取2011年7月—2018年5月择期行内镜下支架置入术的恶性胆道梗阻患者90例,根据随机数表法分为A组和B组,每组45例。A组置入胆道单塑料支架,B组置入胆道金属支架,对比两组支架置入成功、肝功能指标及并发症情况。结果 两组支架置入成功率对比,差异无统计学意义(P>0.05); B组术后3 d时谷氨酰转移酶(glutaminyl transferase,GGT)、碱性磷酸酶(alkaline phosphatase,ALP)、直接胆红素(direct bilirubin,DBIL)及总胆红素(total bilirubin,TBIL)水平均低于A组,差异有统计学意义(P<0.05); B组术后并发症发生率低于A组,差异有统计学意义(P<0.05)。结论 内镜下置入金属胆道金属支架可有效改善患者肝功能,降低并发症发生率,安全性高。
Objective To compare the clinical effects and safety of different endoscopic biliary stent in the treatment of malignant obstruction.Methods A total of 90 malignant obstruction patients with endoscopic stent implantation from July 2011 to May 2018 were selected,and divided into group A and group B by using random number table,with 45 cases in each group.Patients in group A were given biliary plastic stent implantation,while patients in group B were given biliary metallic stent implantation.The success rate of stent implantation,indices of liver function and complications were compared between the two groups.Results There was no statistical difference in the success rate of stent implantation between the two groups (P>0.05).After 3 days of surgery,the levels of glutaminyl transferase (GGT),alkaline phosphatase (ALP),direct bilirubin (DBIL),total bilirubin (TBIL) in group B were lower than those in group A (P<0.05).The incidence rate of postoperative complications in group B was lower than that in group A (P<0.05).Conclusion Endoscopic metallic biliary stent implantation in the treatment of malignant obstruction can effectively improve patients’ liver function and decrease the incidence of complications,which is of safety.
[1] 姚相莉,强化龙,许文青,等.经ERCP途径胆道支架置入术治疗恶性梗阻性黄疸的护理体会[J].中华全科医学,2018,16(7):1208-1211.
[2] 李婷,陶艳婷.内镜下胆管塑料支架引流术治疗恶性胆管梗阻的效果及护理配合[J].安徽医学,2017,38(6):801-803.
[3] 徐刚.经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察[J].临床肝胆病杂志,2018,34(2):337-340.
[4] 蒋翔.开腹与内镜下胆道支架置入治疗晚期恶性梗阻性黄疸的对比分析[J].湖南师范大学学报(医学版),2016,13(4):58-61.
[5] 卜苑雯,孙蓉.两种途径介入治疗低位胆道恶性梗阻的效果分析[J].贵州医药,2018,42(1):61-63.
[6] 齐县伟,李博.经皮肝胆道支架置入与内镜下塑料支架置入治疗恶性梗阻性黄疸疗效对比分析[J].肝胆外科杂志,2018,26(2):115-118.
[7] 王文君,于聪慧.胆道支架引流术对恶性梗阻性黄疸患者肝功能的影响[J].临床肝胆病杂志,2015,31(8):1295-1298.
[8] 张雅敏,田青,杨龙,等.内镜下射频消融联合金属支架置入术治疗肝移植术后胆道恶性梗阻[J].中华消化外科杂志,2017,16(8):874-876.
[9] 闻瑜,王敏荣,许明辉,等.内镜下胆管金属支架引流术治疗恶性胆道梗阻的疗效观察[J].中国医师杂志,2016,18(6):910-913.
[10] 徐旻,范恒伟,刘会春,等.经内镜逆行途径胆道支架置入术治疗68例恶性梗阻性黄疸患者的效果分析[J].中华全科医学,2017,15(1):24-26.
[11] 王蓝博,温锋,郭启勇.经皮胆道金属支架植入治疗恶性梗阻性黄疸术后支架再狭窄的研究进展[J].介入放射学杂志,2017,26(1):77-81.
[12] 李自刚,黄君,王宗云,等.RFA联合胆道自扩式金属支架植入对恶性胆道梗阻患者生化指标及预后的影响[J].西部医学,2018,30(7):1005-1009.
[13] 马竹芳,庞林元.恶性梗阻性黄疸行内镜下胆道金属支架引流术的临床疗效观察[J].现代消化及介入诊疗,2014,29(5):329-331.
[14] 王强,徐继马,姚义荣,等.内镜下肠道金属支架治疗结直肠恶性梗阻的临床研究[J].临床和实验医学杂志,2018,17(5):492-495.
[15] 陈磊,吴益峰,蒋存兵,等.经ERCP胆道金属支架植入治疗不可切除肝外胆道恶性梗阻的安全性及疗效评价[J].中国内镜杂志,2018,24(3):27-31.